Modified Sharp Recanalization for Inferior Vena Cava Occlusion in Patient with Budd-Chiari Syndrome. [PDF]
Koyama S +7 more
europepmc +1 more source
Chylothorax after patent ductus arteriosus ligation in a dog with persistent left cranial vena cava
This report is the first to document chylothorax after patent ductus arteriosus (PDA) ligation in a dog with a persistent left cranial vena cava (PLCVC), highlighting potential complications arising from concurrent cardiovascular anomalies. A nine‐month‐old female desexed Pomeranian was referred for PDA. Echocardiography confirmed a left‐to‐right shunt
TR Nash, GL Hosgood
wiley +1 more source
Superior Vena Cava–Right Pulmonary Artery Anastomosis
Robert A. Achtel +3 more
openalex +1 more source
Effective and safe lead extraction using the bidirectional rotational Evolution\uae sheath in a child with congenital heart disease [PDF]
Cipriani, Alberto +5 more
core +1 more source
Diagnostic and management strategies for retroperitoneal leiomyosarcoma invading the inferior vena cava: a case report. [PDF]
Zhu H, Zhu H.
europepmc +1 more source
Background and Purpose Hypoxic pulmonary hypertension (HPH) is a chronic disorder marked by irreversible pulmonary vascular remodelling (PVR) and pulmonary artery smooth muscle cell (PASMC) dysfunction. Astragaloside IV (AS‐IV), a natural saponin from Astragalus, shows potential in HPH management. This study explores AS‐IV's protective effect on PVR in
Rongzhen Ding +12 more
wiley +1 more source
Letter to the editor: "Budd-Chiari syndrome from pleomorphic sarcoma compressing the inferior vena cava: A case report". [PDF]
Aphale P, Dokania S, Shekhar H.
europepmc +1 more source
A NEW METHOD OF BYPASSING THE OBSTRUCTED VENA CAVA
R Schramel, Henry D.H. Olinde
openalex +1 more source
Deep learning‐enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis
Background and Purpose Myocardial fibrosis (MF), a hallmark of structural cardiac remodelling, drives disease progression across most forms of heart failure and plays a central role in heart failure with preserved ejection fraction (HFpEF). Despite its clinical relevance, effective treatments remain scarce.
Sheyla Barrado‐Ballestero +11 more
wiley +1 more source

